PubMed

ALLHAT, or the soft science of the secondary end point.

Messerli FH.

Ann Intern Med. 2003 Nov 4;139(9):777-80.PMID: 14597462 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic issues in the Antihypertensive and Lipid-Lowering Heart Attack Trial Study.

Punzi HA, Punzi CF; Antihypertensive and Lipid-Lowering Heart Attack Trial Study; Trinity Hypertension Research Institute.

Curr Hypertens Rep. 2004 Apr;6(2):106-10. Review.PMID: 15010012 [PubMed - indexed for MEDLINE]Related articles

Guidelines for antihypertensive treatment: an update after the ALLHAT study.

Salvetti A, Ghiadoni L.

J Am Soc Nephrol. 2004 Jan;15 Suppl 1:S51-4. Review.PMID: 14684673 [PubMed - indexed for MEDLINE]Related articlesFree article

Are thiazide diuretics preferred as first-line therapy for hypertension? An appraisal of The Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Scott I, Stowasser M.

Intern Med J. 2003 Jul;33(7):327-30. No abstract available. PMID: 12823686 [PubMed - indexed for MEDLINE]Related articles

Prescribing patterns for antihypertensive drugs after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: report of experience in a health maintenance organization.

Xie F, Petitti DB, Chen W.

Am J Hypertens. 2005 Apr;18(4 Pt 1):464-9.PMID: 15831354 [PubMed - indexed for MEDLINE]Related articles

Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, Margolis KL, Ong ST, Sadler LS, Summerson J; ALLHAT Collaborative Research Group.

Arch Intern Med. 2006 Nov 13;166(20):2191-201.PMID: 17101936 [PubMed - indexed for MEDLINE]Related articlesFree article

[Why not always diuretics?]

Omvik P, Lund-Johansen P.

Tidsskr Nor Laegeforen. 2004 May 20;124(10):1419-20. Norwegian. PMID: 15195187 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Black HR, Davis B, Barzilay J, Nwachuku C, Baimbridge C, Marginean H, Wright JT Jr, Basile J, Wong ND, Whelton P, Dart RA, Thadani U; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Diabetes Care. 2008 Feb;31(2):353-60. Epub 2007 Nov 13.PMID: 18000186 [PubMed - indexed for MEDLINE]Related articlesFree article

The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.

Einhorn PT, Davis BR, Massie BM, Cushman WC, Piller LB, Simpson LM, Levy D, Nwachuku CE, Black HR; ALLHAT Collaborative Research Group.

Am Heart J. 2007 Jan;153(1):42-53.PMID: 17174636 [PubMed - indexed for MEDLINE]Related articles

ALLHAT: a critical assessment.

Sjöholm A.

Blood Press. 2004;13(2):75-9.PMID: 15182109 [PubMed - indexed for MEDLINE]Related articles

Antihypertensive prescriptions for newly treated patients before and after the main antihypertensive and lipid-lowering treatment to prevent heart attack trial results and seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure guidelines.

Muntner P, Krousel-Wood M, Hyre AD, Stanley E, Cushman WC, Cutler JA, Piller LB, Goforth GA, Whelton PK.

Hypertension. 2009 Apr;53(4):617-23. Epub 2009 Feb 16.PMID: 19221214 [PubMed - indexed for MEDLINE]Related articles

A family physician questions the conclusions from ALLHAT.

Standridge JB.

Am J Hypertens. 2004 Apr;17(4):361-5. Review.PMID: 15062891 [PubMed - indexed for MEDLINE]Related articles

Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Davis BR, Piller LB, Cutler JA, Furberg C, Dunn K, Franklin S, Goff D, Leenen F, Mohiuddin S, Papademetriou V, Proschan M, Ellsworth A, Golden J, Colon P, Crow R; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.

Circulation. 2006 May 9;113(18):2201-10. Epub 2006 May 1.PMID: 16651474 [PubMed - indexed for MEDLINE]Related articlesFree article

What ALLHAT tells us about treating high-risk patients with hypertension and hyperlipidemia.

Geraci TS, Geraci SA.

J Cardiovasc Nurs. 2003 Nov-Dec;18(5):389-95. Review.PMID: 14680343 [PubMed - indexed for MEDLINE]Related articles

Diuretics for cardiovascular prevention in the elderly.

Hanon O, Seux ML, Lenoir H, Rigaud AS, Girerd X, Forette F.

J Hum Hypertens. 2004 Dec;18 Suppl 2:S15-22. Review.PMID: 15592568 [PubMed - indexed for MEDLINE]Related articles

[Clinical study of the month. Which initial antihypertensive? Results from the ALLHAT trial]

Scheen AJ, Krzesinski JM.

Rev Med Liege. 2003 Jan;58(1):47-52. French. PMID: 12647599 [PubMed - indexed for MEDLINE]Related articles

Thiazide diuretics in the treatment of hypertension: an update.

Salvetti A, Ghiadoni L.

J Am Soc Nephrol. 2006 Apr;17(4 Suppl 2):S25-9. Review.PMID: 16565243 [PubMed - indexed for MEDLINE]Related articlesFree article

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.

Davis BR, Cutler JA, Gordon DJ, Furberg CD, Wright JT Jr, Cushman WC, Grimm RH, LaRosa J, Whelton PK, Perry HM, Alderman MH, Ford CE, Oparil S, Francis C, Proschan M, Pressel S, Black HR, Hawkins CM.

Am J Hypertens. 1996 Apr;9(4 Pt 1):342-60.PMID: 8722437 [PubMed - indexed for MEDLINE]Related articles

ALLHAT in perspective: implications to clinical practice and clinical trials.

Yusoff K.

Med J Malaysia. 2005 Jun;60(2):239-45. Review.PMID: 16114170 [PubMed - indexed for MEDLINE]Related articles

Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Wright JT Jr, Harris-Haywood S, Pressel S, Barzilay J, Baimbridge C, Bareis CJ, Basile JN, Black HR, Dart R, Gupta AK, Hamilton BP, Einhorn PT, Haywood LJ, Jafri SZ, Louis GT, Whelton PK, Scott CL, Simmons DL, Stanford C, Davis BR.

Arch Intern Med. 2008 Jan 28;168(2):207-17.PMID: 18227370 [PubMed - indexed for MEDLINE]Related articlesFree article